ODM derived from


Versions (2) ▾
  1. 12/9/13
  2. 9/17/21
Uploaded on:

September 17, 2021

No DOI assigned. To request one please log in.
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00683930 Pemphigus Vulgaris (PV)


  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age 18 Years to 70 Years
Adulthood (qualifier value)
Diagnosis of mild to moderate pemphigus vulgaris within the past 12 months, requiring high dose corticosteroids
Exclusion Criteria
Female patients who are pregnant, breastfeeding, or lactating
Regularly scheduled plasma exchange (PE) or intravenous immunoglobulin (IVIG) treatment, or PE or IVIG treatment within 8 weeks prior to randomization
CellCept or other immunosuppressive therapy, except corticosteroids, exceeding 2 weeks total duration and within 8 weeks prior to randomization
Use of PV therapies other than those noted above, within 4 weeks prior to randomization
Use of topical corticosteroids within 2 weeks prior to randomization

Similar models